Related Experiment Video

Updated: Aug 9, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

977

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies

Hany E Marei1, Carlo Cenciarelli2

  • 1Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35116, Egypt.

Biomedicines
|February 25, 2023
PubMed

Insights

Chimeric antigen receptor T-cell (CAR-T) therapy shows promise for aggressive tumors beyond blood cancers. This approach offers new hope where traditional treatments have failed.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cellular Therapy

Background:

  • CAR-T cell therapy has demonstrated significant efficacy in treating CD19-positive hematological malignancies.
  • This success provides a strong foundation for exploring CAR-T therapy in other cancer types.

Discussion:

  • The potential of CAR-T therapy extends to aggressive solid tumors that are often refractory to current treatments.
  • Investigating novel targets and optimizing CAR-T constructs are crucial for broader application.

Key Insights:

  • CAR-T therapy's effectiveness in blood cancers suggests its adaptability to other malignancies.
  • There is a critical need for therapies targeting aggressive tumors with limited treatment options.

Outlook:

  • Further research into CAR-T cell therapy holds potential for treating a wider range of aggressive cancers.
  • Advancements in this field could revolutionize treatment paradigms for previously intractable diseases.

More Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.4K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K